Related Experiment Video
Updated: Nov 17, 2025

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
Published on: November 30, 2022
COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-embolism
Sergi Bellmunt-Montoya1, Claudia Riera2, Daniel Gil1
1Angiology and Vascular Surgery Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (UAB), Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.
Insights
Critically ill COVID-19 patients have a high risk of venous thrombo-embolism (VTE), with over 26% experiencing VTE. D-dimer levels above 1500 ng/mL indicate VTE, and increased prophylaxis may be needed.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Hematology
Background:
- COVID-19 infection is associated with an elevated risk of venous thrombo-embolism (VTE).
- Understanding the frequency and risk factors for VTE in critically ill COVID-19 patients is crucial for effective management.
Purpose of the Study:
- To determine the incidence of VTE in critically ill COVID-19 patients.
- To investigate the correlation between VTE and D-dimer levels.
- To assess the effectiveness of pharmacological prophylaxis in preventing VTE.
Main Methods:
- A cohort study involving critically ill COVID-19 patients admitted to the ICU.
- Venous duplex ultrasound and computed tomography angiography were used to diagnose VTE.
- Data collected included patient characteristics, blood test results, thromboprophylaxis, VTE events, and mortality.
Main Results:
- VTE occurred in 26.5% of critically ill COVID-19 patients (45 DVT, 16 PE).
- D-dimer levels ≥ 1500 ng/mL were diagnostic of VTE with 80% sensitivity.
- New VTE events and recurrences were observed despite therapeutic anticoagulation.
Conclusions:
- Critically ill COVID-19 patients face a significant risk of VTE.
- Anticoagulant prophylaxis may require dose adjustments in certain patients to mitigate bleeding risk.
- Further research into optimal VTE prevention strategies for this population is warranted.
Objective:
The coronavirus disease of 2019 (COVID-19) due to SARS-CoV-2 infection has been found to cause an increased risk of venous thrombo-embolism (VTE). The aims of the study were to determine the frequency of VTE in critically ill patients with COVID-19 and its correlation with D dimer levels and pharmacological prophylaxis.
Methods:
This was a cohort study of critically ill patients due to COVID-19. All patients admitted to the intensive care unit on the same day of April 2020 were selected, regardless of length of stay, and a single bilateral venous duplex ultrasound in the lower extremities was performed up to 72 hours later. Pulmonary embolism (PE) was diagnosed by computed tomography angiography. Asymptomatic and symptomatic VTE were registered, including pre-screening in hospital VTE. Characteristics of patients, blood test results, doses of thromboprophylaxis received, VTE events, and mortality after seven day follow up were recorded.
Results:
A total of 230 critically ill patients were studied. The median intensive care unit stay of these patients was 12 days (interquartile range [IQR] 5 - 19 days). After seven days follow up, the frequency of patients with VTE, both symptomatic and asymptomatic, was 26.5% (95% confidence interval [CI] 21% - 32%) (69 events in 61 patients): 45 with DVT and 16 with PE (eight of them with concomitant DVT). The cumulative frequency of symptomatic VTE was 8.3% (95% CI 4.7% - 11.8%). D dimer values ≥ 1 500 ng/mL were diagnostic of VTE, with a sensitivity of 80% and a specificity of 42%. During follow up after screening, six patients developed new VTE. Three of them developed a recurrence after a DVT diagnosed at screening, despite receiving therapeutic doses of heparin. Mortality rates at seven day follow up were the same for those with (6.6%) and without (5.3%) VTE.
Conclusion:
Patients with severe COVID-19 infection are at high risk of VTE, and further new symptomatic VTE events and recurrence can occur despite anticoagulation. The prophylactic anticoagulant dose may need to be increased in patients with a low risk of bleeding.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management

